LUNG Q3 2024 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M+15.4% YoY

Gross Profit

$15M73.7% margin

Operating Income

-$14M-69.3% margin

Net Income

-$14M-69.4% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-1.9%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$167M

Total Liabilities

$73M

Stockholders' Equity

$94M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$18M	+15.4%
Gross Profit	$15M	$13M	+15.3%
Operating Income	-$14M	-$15M	+6.9%
Net Income	-$14M	-$15M	+5.1%

Geographic Segments

UNITED STATES

$14M68%

EMEA

$5M25%

Asia Pacific

$1M6%

Other International Geographical Areas

$145,0001%